facebook

24/7 Market News- Kraig Biocraft Laboratories Transfers Onsite Testing and Screening of Transgenics Technology to its Prodigy subsidiary

Equipment transfer positions Prodigy to expedite production expansion and next-generation disease-resistant silkworms

DENVER, Colo., – June 7, 2021– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces the transfer of its onsite testing and screening of transgenics technology to Prodigy Textiles, the Company’s Vietnam based subsidiary.

The Company made the significant decision to transfer testing and screening technologies from its R&D headquarters in the US to its factory in Vietnam.  This testing equipment allows for precise screening and selection of the transgenics’ key genetic traits, which are currently conducted exclusively at the Company’s US headquarters.  Implementing this testing onsite eliminates the delay caused by transferring samples between the US and Vietnam and further strengthens the Company’s continued production operations against future challenges related to travel restrictions.  This new laboratory equipment is in addition to the recently reported production automation equipment that is being installed at the same facility.

This new testing capability will also support the Company’s development program to produce new disease-resistant strains of silkworms.  These new disease-resistant lines of silkworms are intended for licensing into the global market for mundane silks to combat pathogenic virus and fungi that account for the loss of approximately 20% of the typical global annual silk production.[1]

“This move will dramatically increase our production efficiency and reduce costs of operations.  The labs at Prodigy will be fully equipped to conduct all material performance and genetic screening in real-time.  This technology transfer, coupled with the investment in equipment and staffing, will speed up our commercial production ramp-up while eliminating a log jam in operations and is expected to be online within 60 days.  Simultaneously, our US R&D team will be freed to focus its attention on bringing next-generation transgenics and materials to market,” said COO Jon Rice.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

[1] Gani, Mudasir & Chouhan, Sahadev & Lal, Babu & Gupta, Rakesh & Rohela, Gulab & Neelaboina, Bharath & Saini, Pawan & Ghosh, M.. (2018). Bombyx mori nucleopolyhedrovirus (BmNPV): Its impact on silkworm rearing and management strategies. Biological Control. 31. 10.18311/jbc/2017/16269.

Connect with 24/7 Market News on social media:

https://twitter.com/247MarketNewsHQ

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

Materials in this release are informational and should never be considered research. You must do your own due diligence by reading all available public information. This release is a corporate public statement, and believed to be reliable. The principle and editor of 24/7 has been compensated by Kraig Labs in the past, and still owns shares received years ago, which he can and will sell anytime. The editor can, will and is selling his stock as he deems necessary at any time of his choosing which could be viewed as a conflict of interest. 24/7 makes no representations and warranties to the completeness of materials provided and are subject to change without notice. 24/7 is not responsible for any gains or losses which result from our opinions or coverage expressed in our emails or our site and readers are cautioned that investing has risks and you may lose all or a portion of your money.

For further information on 24/7 Market News, please go to www.247marketnews.com

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT:

24/7 Market News

Editor@247marketnews.com

Welcome Back!

Login to your account below

Create New Account!

Fill the forms below to register

Retrieve your password

Please enter your username or email address to reset your password.

Share via
Send this to a friend
Hi, this may be interesting you: 24/7 Market News- Kraig Biocraft Laboratories Transfers Onsite Testing and Screening of Transgenics Technology to its Prodigy subsidiary! This is the link: https://www.247marketnews.com/press-releases/24-7-market-news-kraig-biocraft-laboratories-transfers-onsite-testing-and-screening-of-transgenics-technology-to-its-prodigy-subsidiary/